Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1Areceptors
Top Cited Papers
Open Access
- 19 January 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 159 (1), 122-128
- https://doi.org/10.1111/j.1476-5381.2009.00521.x
Abstract
Background and purpose: Cannabidiol (CBD) is a non-psychotomimetic compound from Cannabis sativa that induces anxiolytic- and antipsychotic-like effects in animal models. Effects of CBD may be mediated by the activation of 5-HT1A receptors. As 5-HT1A receptor activation may induce antidepressant-like effects, the aim of this work was to test the hypothesis that CBD would have antidepressant-like activity in mice as assessed by the forced swimming test. We also investigated if these responses depended on the activation of 5-HT1A receptors and on hippocampal expression of brain-derived neurotrophic factor (BDNF). Experimental approach: Male Swiss mice were given (i.p.) CBD (3, 10, 30, 100 mg.kg(-1)), imipramine (30 mg.kg(-1)) or vehicle and were submitted to the forced swimming test or to an open field arena, 30 min later. An additional group received WAY100635 (0.1 mg.kg(-1), i.p.), a 5-HT1A receptor antagonist, before CBD (30 mg.kg(-1)) and assessment by the forced swimming test. BDNF protein levels were measured in the hippocampus of another group of mice treated with CBD (30 mg.kg(-1)) and submitted to the forced swimming test. Key results: CBD (30 mg.kg(-1)) treatment reduced immobility time in the forced swimming test, as did the prototype antidepressant imipramine, without changing exploratory behaviour in the open field arena. WAY100635 pretreatment blocked CBD-induced effect in the forced swimming test. CBD (30 mg.kg(-1)) treatment did not change hippocampal BDNF levels. Conclusion and implications: CBD induces antidepressant-like effects comparable to those of imipramine. These effects of CBD were probably mediated by activation of 5-HT1A receptors. British Journal of Pharmacology (2010) 159, 122-128; doi:10.1111/j.1476-5381.2009.00521.x; published online 4 December 2009Keywords
This publication has 74 references indexed in Scilit:
- 5-HT1A receptor function in major depressive disorderProgress in Neurobiology, 2009
- 5‐HT1A receptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in ratsBritish Journal of Pharmacology, 2008
- Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatmentJournal of Neurochemistry, 2008
- Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorderInternational Journal of Neuropsychopharmacology, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?Behavioural Pharmacology, 2005
- Complex pharmacology of natural cannabivoids: Evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptorsLife Sciences, 1998
- ACTIVATION OF SEROTONERGIC 5-HT1A RECEPTOR REDUCES Ca2+- AND GLUTAMATERGIC RECEPTOR-EVOKED ARACHIDONIC ACID AND NO/cGMP RELEASE IN ADULT HIPPOCAMPUSNeurochemistry International, 1996
- Inhibition of the cataleptic effect of tetrahydrocannabinol by other constituents of Cannabis sativa L.Journal of Pharmacy and Pharmacology, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976